Ticker Details
Alto Neuroscience Inc.
IPO Date:	February 2, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$715.58M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 4.24%
Avg Daily Range (30 D):	$0.83 | 3.92%
Avg Daily Range (90 D):	$0.70 | 3.86%

Institutional Daily Volume
Avg Daily Volume:	.39M
Avg Daily Volume (30 D):	.26M
Avg Daily Volume (90 D):	.25M

Trade Size
Avg Trade Size (Sh.):	98
Avg Trade Size (Sh.) (30 D):	63
Avg Trade Size (Sh.) (90 D):	63

Institutional Trades
Total Institutional Trades:	112
Avg Institutional Trade:	$1.46M
Avg Institutional Trade (30 D):	$.91M
Avg Institutional Trade (90 D):	$1.21M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.98M
Avg Closing Trade (30 D):	$1.4M
Avg Closing Trade (90 D):	$2.49M
Avg Closing Volume:	266.36K

News

Feb 26, 2026 @ 5:07 PM Psychedelic Medicine Advances: Here Are Five Compa... Source: Prnewswire

Oct 7, 2025 @ 10:05 PM ALTO ALERT: Bragar Eagel & Squire, P.C. is Investi... Source: Bragar Eagel & Squire, P.C.

Sep 19, 2025 @ 8:49 PM Investors who lost money on Alto Neuroscience, Inc... Source: Levi & Korsinsky, Llp

Sep 19, 2025 @ 1:50 PM ANRO DEADLINE TODAY: ROSEN, A HIGHLY RECOGNIZED LA... Source: Rosen Law Firm

Sep 18, 2025 @ 8:00 PM ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.3	$-.52
Diluted EPS	$-2.3	$-.52
Revenue	$M	$M
Gross Profit
Net Income / Loss	$-62.26M	$-14.18M	$-17.71M
Operating Income / Loss	$-66.31M	$-14.95M
Cost of Revenue
Net Cash Flow	$-43.89M
PE Ratio